Carole Ho - Aug 23, 2023 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Chief Medical Officer
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Aug 23, 2023
Transactions value $
-$58,561
Form type
4
Date filed
8/25/2023, 05:30 PM
Previous filing
Aug 23, 2023
Next filing
Jan 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale -$58.6K -2.52K -1.36% $23.22 183K Aug 23, 2023 See footnote F1, F2
holding DNLI Common Stock 25K Aug 23, 2023 See footnote F3
holding DNLI Common Stock 109K Aug 23, 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted March 30, 2022.
F2 The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.
F3 The shares are held of record by The Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.
F4 Includes 108,714 RSUs.